UK markets closed

Bionano Genomics, Inc. (0A4K.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
1.3700-0.0695 (-4.83%)
At close: 02:49PM BST
Sign in to post a message.
  • J
    All these new BNGO patents they have add to the value to the company. BNGO is a growth stock winner and these new patents will pay off. Many little's make a lot and these innovative patents are money in the bank. BNGO Genomic's innovative technology portfolio just keeps getting bigger better. BNGO is already recognized as having the best most deeper detailed OGM Optical Genome Mapping available with cost saving plus faster results and in use now U.S , Canada, Europe, Asia, South America. Just added more to my invsetment in BNGO today again, back $10 in 2022 is still in the equation
  • Z
    Hey happy 4th of July........added more shares of BNGO today. With my current investment holdings of BNGO eventually go to $10 or $20 or higher 2022/2023 would be a $300K-$600K gain from this very promising Genomics Technology company BNGO..........yesser you betcha it's very possible Buy&Hold
  • B
    BNGO bull s
    Waiting for great on sales in Q2. Come on BNGO. Dont let us down.
  • t
    Will be GREEN today!! BNGO granted patent by FDA!! in the news this morning!!
  • D
    BNGO trading at near book value growing revenue at 80% across the world.
  • R
    BNGO is the TSLA of genomics.
    8,452 shares so far. Planning to add more tomorrow morning no matter what John says about it.
  • G
    BNGO has the the most advanced OGM Genomics tecnology in the world The overwhelming data from U.S., Cnanada, Europe, India, China etc. etc. has shown this fact. BNGO buy&hold going back over $10 again
  • R
    BNGO is the TSLA of genomics. Keep that in mind.
  • R
    The S&P 500 just finished the worst first half of a year since 1962. The Nasdaq and growth stocks have fared even worse. But things will eventually turn around. 👍
  • f
    Have you guys ever heard of ( The picks on there are way better than BNGO
  • t
    LETS GO!!!
  • M
    Has BNGO projected a date when it turns profitable?
  • R
    I added 182 shares today.
    BNGO is the TSLA of genomics!
  • V
    Lot of noise have been coming out of European nations lately. Mostly good news EACR 2022 is a four-day congress dedicated to basic, preclinical, and translational cancer research. EACR sessions will take place June 20-23, 2022 in Seville, Spain. Bionano will exhibit all of its solutions relevant to cancer research, including the Saphyr system, NxClinical software, and expert laboratory services. The latest version of NxClinical software, version 6.2, includes integrated genomic scar analysis for homologous recombination deficiency (HRD). This feature provides a comprehensive, consistent, and automated analysis of biomarkers from next-generation sequencing (NGS) and microarray data that can help clinical researchers stratify therapeutic response across multiple tumor types. We should see the stock increasing in price.
  • r
    10 soon!
  • T
    According to 9 analysts, the average rating for BNGO stock is "Buy." The 12-month stock price forecast is 8.84, which is an increase of 503.41% from the latest price.

    Price Target


    (503.41% upside)

    Analyst Consensus: Buy
  • E
    $300 by 2025!
  • J
    BNGO #$%$ coming
  • s
    scott d
    This is what happens when you let a 15yo girl run the worlds energy policy.